Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome

On the basis of limited experimental and clinical studies, increased activity of the vasodilatory nitric oxide–cyclic guanosine monophosphate pathway is considered to play a key role in the pathogenesis of hepatopulmonary syndrome. We report a 46-year-old woman with Child–Pugh class C cirrhosis and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of gastroenterology & hepatology 2007-04, Vol.19 (4), p.341-346
Hauptverfasser:	Almeida, John A, Riordan, Stephen M, Liu, Jia, Galhenage, Sumedha, Kim, Robert, Bihari, David, Wegner, Eva A, Cranney, Gregory B, Thomas, Paul S
Format:	Artikel
Sprache:	eng
Schlagworte:	Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Biological and medical sciences Blood Pressure - drug effects Cardiovascular system Chronic Disease Curcumin - adverse effects Curcumin - therapeutic use Cyclic GMP - antagonists & inhibitors Echocardiography Female Gastroenterology. Liver. Pancreas. Abdomen Hepatopulmonary Syndrome - diagnosis Hepatopulmonary Syndrome - drug therapy Hepatopulmonary Syndrome - physiopathology Humans Investigative techniques, diagnostic techniques (general aspects) Liver. Biliary tract. Portal circulation. Exocrine pancreas Lypressin - adverse effects Lypressin - analogs & derivatives Lypressin - therapeutic use Medical sciences Methylene Blue - adverse effects Methylene Blue - therapeutic use Middle Aged Nitric Oxide - antagonists & inhibitors Other diseases. Semiology Pneumology Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases Treatment Failure Ultrasonic investigative techniques Vascular Resistance - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!